Bispecific antibodies (bsAbs): promising immunotherapeutic agents for cancer therapy
DO Acheampong, CK Adokoh… - Protein and peptide …, 2017 - ingentaconnect.com
Antibodies have become the preferred therapeutic treatment option for cancers. Antibody
therapy is associated with low toxic profile and specific in its activity, unlike chemotherapy …
therapy is associated with low toxic profile and specific in its activity, unlike chemotherapy …